Withuspharmaceutical Co.Ltd (330350.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea

Price
6,390.00 KRW
Market cap
84.35 bn KRW
P/E (2025)
16.98
P/S (2025)
0.79
Dividend yield
0.00 %
Net margin
4.67 %
Return on equity (ROE)
5.07 %
Return on assets (ROA)
3.64 %

Withuspharmaceutical Co.Ltd financials

Fiscal year20242025
Revenue102.72 bn KRW106.44 bn KRW
Gross profit65.55 bn KRW68.83 bn KRW
Operating income5.46 bn KRW5.66 bn KRW
EBIT5.95 bn KRW5.23 bn KRW
Net income4.78 bn KRW4.97 bn KRW
Diluted EPS – continuing operations362.49 KRW376.31 KRW

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Withuspharmaceutical Co.Ltd

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name to WITHUS PHARMACEUTICAL Co.,LTD. in October 2007. WITHUS PHARMACEUTICAL Co.,LTD. was founded in 2004 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.